1 / 6

Lung Cancer Pipeline Clinical Trial Review 2015

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development

john2222deere
Télécharger la présentation

Lung Cancer Pipeline Clinical Trial Review 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lung Cancer - Pipeline Review, 2015 By RnRMarketResearch.com Publisher Name : GlobalData Date: 01-Oct-2015 No. of pages: 285 Single User License: US $4000 Browse more Reports on Surgical Equipment at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices/surgical-equipment . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Lung Cancer - Pipeline Review, 2015 The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Lung Cancer diagnostic tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by our team of industry experts. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Lung Cancer - Pipeline Review, 2015 Companies Discussed/Mentioned in this Research: A&G Pharmaceutical Inc., Abbott Diagnostics, Abcodia Ltd., Aberystwyth University, Advanced Marker Discovery S.L., Advpharma Inc., Almac Diagnostics Limited, ArmuneBioScience Inc., AureliumBioPharma Inc., Biocept Inc., Biodesix Inc., BioMark Diagnostics Inc., BioMark Technologies Inc., BioMarker Strategies LLC, Biomoda Inc., BioNTech AG, BioSystems International, BioTime Inc., Boise State University, Cancer Research Technology Limited, Cangen Biotechnologies Inc., Celera Corporation, Cellanyx Diagnostics Inc., CellMax Life, CeMines Inc., Cepheid, Ceres Nanosciences, Inc., Cernostics Inc., ChemImage Corporation, Chronix Biomedical Inc., Clarient Inc., Courtagen Life Sciences Inc., Dako, Dartmouth College, DiagnoCure Inc., EDP Biotech Corporation, Emory University, Epigenomics AG, Eventus Diagnostics, Inc., Exact Sciences Corporation, Exiqon, Exosomics Siena SpA, Fina Biotech, Fluxion Biosciences Inc., ForschungszentrumBorstel, Gene Express Inc., GeneCentric Diagnostics Inc., Genentech Inc., GenomicTree Inc. and more… ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Lung Cancer - Pipeline Review, 2015 Scope For Lung Cancer - Pipeline Review, 2015 • Extensive coverage of the Lung Cancer diagnostic tests under development • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities • The report reviews the major players involved in the development of Lung Cancer diagnostic tests and list all their pipeline projects • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage • The report provides key clinical trial data of ongoing trials specific to pipeline products • Recent developments in the segment / industry ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Lung Cancer - Pipeline Review, 2015 Reasons to Buy: • Formulate significant competitor information, analysis, and insights to improve R&D strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Identify and understand important and diverse types of Lung Cancer diagnostic tests under development • Develop market-entry and market expansion strategies • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline • In-depth analysis of the product's current stage of development, territory and estimated launch date ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Lung Cancer - Pipeline Review, 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related